Association Between Metabolic Syndrome and Decline in Cognitive Function: A Cross-Sectional Study

References

• Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101. PMID: 28109251; PMCID: PMC5251315. doi:10.1186/s12889-017-4041-1
   PubMed Web of Science ®Google Scholar
• Al-Thani MH, Al-Thani AAM, Cheema S, et al. Prevalence and determinants of metabolic syndrome in Qatar: results from a national health survey. BMJ Open. 2016;6(9):e009514. doi:10.1136/bmjopen-2015-009514
   PubMed Web of Science ®Google Scholar
• Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–414. doi:10.1016/j.jacc.2006.09.032
   PubMed Web of Science ®Google Scholar
• Avadhani R, Fowler K, Barbato C, et al. Glycemia and cognitive function in metabolic syndrome and coronary heart disease. Am J Med. 2015;128(1):46–55. doi:10.1016/j.amjmed.2014.08.025
   PubMed Web of Science ®Google Scholar
• Neergaard J, Dragsbæk K, Christiansen C, et al. Metabolic syndrome, insulin resistance, and cognitive dysfunction: does your metabolic profile affect your brain? Diabetes. 2017;66(7):1957–1963. doi:10.2337/db16-1444
   PubMed Web of Science ®Google Scholar
• Pal K, Mukadam N, Petersen I, Cooper C. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2018;53(11):1149–1160. doi:10.1007/s00127-018-1581-3
   PubMed Web of Science ®Google Scholar
• Haase Alasantro L, Hicks T, Green-Krogmann E, Murphy C. Metabolic syndrome and cognitive performance across the adult lifespan. PLoS One. 2021;16(5):e0249348. doi:10.1371/journal.pone.0249348
   PubMed Web of Science ®Google Scholar
• Al Kuwari H, Al Thani A, Al Marri A, et al. The Qatar Biobank: background and methods. BMC Public Health. 2015;15:1. doi:10.1186/s12889-015-2522-7
   PubMed Web of Science ®Google Scholar
• Meigs JB. Metabolic syndrome (insulin resistance syndrome or syndrome X); 2019. Available from: https://www-uptodate-com.qulib.idm.oclc.org/contents/metabolic-syndrome-insulin-resistance-syndrome-or-syndrome-x?search=metabolic+syndrome+criteria+atp+iii&topicRef=15278&source=see_link. Accessed: January 26, 2023.
   Google Scholar
• Cambridge Cognition Limited. Cantab Research Suite 6 Test Administration Guide. 6th ed. Cambridge Cognition Limited; 2014.
   Google Scholar
• Alfaro FJ, Lioutas VA, Pimentel DA, et al. Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities. J Neurol. 2016;263(12):2505–2514. doi:10.1007/s00415-016-8292-z
   PubMed Web of Science ®Google Scholar
• Collinson SL, Tong SJ, Loh SS, Chionh SB, Merchant RA. Midlife metabolic syndrome and neurocognitive function in a mixed Asian sample. Int Psychogeriatr. 2014;26(8):1305–1316. doi:10.1017/S104161021400057X
   PubMed Web of Science ®Google Scholar
• Bird C, Burgess N. The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci. 2008;9(3):182–194. doi:10.1038/nrn2335
   PubMed Web of Science ®Google Scholar
• Lamar M, Rubin LH, Ajilore O, et al. What metabolic syndrome contributes to brain outcomes in African American & caucasian cohorts. Curr Alzheimer Res. 2015;12(7):640–647. doi:10.2174/1567205012666150701102325
   PubMed Web of Science ®Google Scholar
• Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC. Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. J Alzheimers Dis. 2014;41(1):151–161.
   PubMed Web of Science ®Google Scholar
• Yates K, Sweat V, Yau P, Turchiano M, Convit A. Impact of metabolic syndrome on cognition and brain. Arterioscler Thromb Vasc Biol. 2012;32(9):2060–2067. doi:10.1161/atvbaha.112.252759
   PubMed Web of Science ®Google Scholar
• García-Casares N, Jorge RE, García-Arnés JA, et al. Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study. J Alzheimers Dis. 2014;42(4):1337–1346. doi:10.3233/JAD-140702
   PubMed Web of Science ®Google Scholar
• Reitz C, Luchsinger J, Tang M, Manly J, Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology. 2005;64(8):1378–1383. doi:10.1212/01.wnl.0000158274.31318.3c
   PubMed Web of Science ®Google Scholar
• Zhan C, Wang Q, Liu J, et al. Relationship between metabolic syndrome and cognitive function: a population-based study of middle-aged and elderly adults in rural China. Diabetes Metab Syndr Obes. 2021;14:1927–1935. doi:10.2147/dmso.s308250
   PubMed Web of Science ®Google Scholar
• Weyman-Vela Y, Simental-Mendía LE, Camacho-Luis A, Gamboa-Gómez CI, Guerrero-Romero F. The triglycerides and glucose index is associated with mild cognitive impairment in older adults. Endocr Res. 2022;47(2):89–93. doi:10.1080/07435800.2022.2061508
   PubMed Web of Science ®Google Scholar
• Li S, Deng X, Zhang Y. The triglyceride-glucose index is associated with longitudinal cognitive decline in a middle-aged to elderly population: a cohort study. J Clin Med. 2022;11(23):7153. doi:10.3390/jcm11237153
   PubMed Web of Science ®Google Scholar
• Tong X-W, Zhang Y-T, Yu Z-W, et al. Triglyceride glucose index is related with the risk of mild cognitive impairment in type 2 diabetes. Diabetes Metab Syndr Obes. 2022;15:3577–3587. doi:10.2147/dmso.s389327
   PubMed Web of Science ®Google Scholar
• Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junqué C. Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett. 2009;462(1):49–53. PMID: 19560512. doi:10.1016/j.neulet.2009.06.071
   PubMed Web of Science ®Google Scholar
• Abbatecola AM, Lattanzio F, Spazzafumo L, et al. Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up. PLoS One. 2010;5(4):e10333. doi:10.1371/journal.pone.0010333
   PubMed Web of Science ®Google Scholar
• Kerwin DR, Gaussoin SA, Chlebowski RT, et al. Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the women’s health initiative memory study. J Am Geriatr Soc. 2011;59(1):107–112. doi:10.1111/j.1532-5415.2010.03219.x
   PubMed Web of Science ®Google Scholar
• Shen J, Yu H, Li K, Ding B, Xiao R, Ma W. The association between plasma fatty acid and cognitive function mediated by inflammation in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:1423–1436. doi:10.2147/dmso.s353449
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Archiv Med Sci. 2017;4:851–863. doi:10.5114/aoms.2016.58928
   Google Scholar
• Kordestani-Moghadam P, Assari S, Nouriyengejeh S, Mohammadipour F, Pourabbasi A. Cognitive impairments and associated structural brain changes in metabolic syndrome and implications of neurocognitive intervention. J Obes Metab Syndr. 2020;29(3):174–179. doi:10.7570/jomes20021
   PubMed Web of Science ®Google Scholar
• Kouvari M, Karipidou M, Tsiampalis T, et al. Digital health interventions for weight management in children and adolescents: systematic review and meta-analysis. J Med Internet Res. 2022;24:2. doi:10.2196/30675
   Web of Science ®Google Scholar
• Barrea L, Annunziata G, Muscogiuri G, et al. Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients. 2018;10(12):1971. doi:10.3390/nu10121971
   PubMed Web of Science ®Google Scholar
• Li D, Ke Y, Zhan R, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell. 2018;17(4):e12768. doi:10.1111/acel.12768
   PubMed Web of Science ®Google Scholar
• Connell E, Le Gall G, Pontifex MG, et al. Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia. Mol Neurodegener. 2022;17(1):43. doi:10.1186/s13024-022-00548-6
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang C, Cao G, Dong X, Li D, Jiang L. Higher circulating trimethylamine n-oxide sensitizes sevoflurane-induced cognitive dysfunction in aged rats probably by downregulating hippocampal methionine sulfoxide reductase A. Neurochem Res. 2019;44(11):2506–2516. doi:10.1007/s11064-019-02868-4
   PubMed Web of Science ®Google Scholar
• Ownby RL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep. 2010;12(1):39–45. doi:10.1007/s11920-009-0082-1
   PubMed Web of Science ®Google Scholar
• Voss JL, Bridge DJ, Cohen NJ, Walker JA. A closer look at the hippocampus and memory. Trends Cogn Sci. 2017;21(8):577–588. doi:10.1016/j.tics.2017.05.008
   PubMed Web of Science ®Google Scholar
• Mungas D, Gavett B, Fletcher E, Farias ST, DeCarli C, Reed B. Education amplifies brain atrophy effect on cognitive decline: implications for cognitive reserve. Neurobiol Aging. 2018;68:142–150. doi:10.1016/j.neurobiolaging.2018.04.002
   PubMed Web of Science ®Google Scholar
• Wilson RS, Hebert LE, Scherr PA, Barnes LL, de Leon M, Evans DA. Educational attainment and cognitive decline in old age. Neurology. 2009;72(5):460–465. doi:10.1212/01.wnl.0000341782.71418.6c
   PubMed Web of Science ®Google Scholar
• Mather M, Cacioppo JT, Kanwisher N. How fMRI can inform cognitive theories. Perspect Psychol Sci. 2013;8(1):108–113. doi:10.1177/1745691612469037
   PubMedGoogle Scholar